Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | JOHNSON & JOHNSON | $372.17B | $154.64 | $176.88 | 14.38% | Buy | 8 | 4.61% | -9.18% | 41.90% | 17.06% | ||||
SNY | SANOFI | $123.12B | $48.67 | $55.00 | 13.01% | Hold | 1 | 5.01% | 35.94% | N/A | N/A | ||||
AZN | ASTRAZENECA PLC | $238.42B | $76.90 | $83.50 | 8.58% | Strong Buy | 2 | 7.50% | 42.12% | N/A | N/A | ||||
LLY | ELI LILLY & CO | $731.81B | $770.00 | $845.07 | 9.75% | Strong Buy | 15 | 19.92% | 46.03% | N/A | N/A | ||||
NVS | NOVARTIS AG | $209.28B | $102.57 | $115.00 | 12.12% | Hold | 2 | 2.38% | 2.37% | N/A | N/A | ||||
BIIB | BIOGEN INC | $33.57B | $230.57 | $283.40 | 22.91% | Buy | 20 | 0.56% | 31.34% | N/A | N/A | ||||
GSK | GSK PLC | $90.95B | $44.98 | $46.00 | 2.27% | Buy | 2 | 5.43% | 39.53% | N/A | N/A | ||||
ABBV | ABBVIE INC | $293.88B | $166.42 | $183.75 | 10.41% | Strong Buy | 8 | 5.11% | 59.79% | N/A | N/A | ||||
MRK | MERCK & CO INC | $332.28B | $131.19 | $136.00 | 3.67% | Buy | 8 | 6.34% | 128.59% | 72.82% | 27.77% | ||||
GILD | GILEAD SCIENCES INC | $84.37B | $67.72 | $80.91 | 19.48% | Buy | 11 | 1.50% | 159.87% | N/A | N/A | ||||
AMGN | AMGEN INC | $167.62B | $312.47 | $321.36 | 2.85% | Buy | 11 | 5.51% | 43.72% | N/A | N/A | ||||
BMY | BRISTOL MYERS SQUIBB CO | $89.25B | $44.03 | $51.40 | 16.74% | Hold | 5 | -0.56% | N/A | N/A | N/A | ||||
OGN | ORGANON & CO | $5.61B | $21.80 | $22.00 | 0.92% | Buy | 2 | 0.27% | 15.03% | N/A | N/A | ||||
GRFS | GRIFOLS SA | $5.29B | $7.70 | $10.50 | 36.36% | Hold | 1 | 7.84% | 1,064.95% | 13.50% | 3.67% | ||||
PFE | PFIZER INC | $162.29B | $28.64 | $33.63 | 17.41% | Buy | 8 | 4.29% | N/A | 19.14% | 7.99% | ||||
SCLX | SCILEX HOLDING CO | $163.07M | $0.90 | $8.00 | 788.89% | Buy | 1 | 41.78% | N/A | N/A | N/A | ||||
AMRN | AMARIN CORP PLC | $357.46M | $0.87 | N/A | N/A | N/A | N/A | -13.86% | N/A | N/A | N/A | ||||
MIRA | MIRA PHARMACEUTICALS INC | $9.68M | $0.66 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |